期刊文献+

安丝菌素P-3的发酵工艺 被引量:9

Fermentation Process for the Production of Ansamitocin P-3
原文传递
导出
摘要 考察了珍贵橙色束丝放线菌SIPI-3-21生产安丝菌素P-3(AP-3)的发酵工艺。首先优化了摇瓶发酵培养基配方,在含葡萄糖20.0 g/L、玉米淀粉30.0 g/L、棉籽饼粉30.0 g/L、CaCl2 10.0 g/L和CaCO3 5.0 g/L的发酵培养基中发酵培养9 d,AP-3产量为123.2 mg/L。进一步在摇瓶中考察了前体异丁醇对AP-3合成的影响,结果表明,添加异丁醇可以显著提高AP-3的产量。当其添加浓度为54 mmol/L时,AP-3的产量为307.8 mg/L,同时发酵液中AP-3的含量从57.2%提高到86.5%。 The fermentation process for the production of ansamitocin P-3 (AP-3) by Actinosynnema pretiosum SIPI-3-21 was investigated. By optimization of fermentation medium, the yield of AP-3 reached 123.2 mg/L in the medium containing glucose 20.0 g/L, corn starch 30.0 g/L, cotton seed meal 30.0 g/L, CaC12 10.0 g/L and CaCO35.0 g/L, cultured for 9 days in a shake flask. The effect of isobutanol on AP-3 production was also investigated. The results showed that the titer of AP-3 was 307.8 mg/L after feeding 54 mmol/L isobutanol during the fermentation process, and the component of AP-3 in the fermentation broth was increased from 57.2 % to 86.5 %.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2012年第4期260-262,293,共4页 Chinese Journal of Pharmaceuticals
基金 微生物药物技术创新与新药创制产学研联盟(2010ZX09401-403)
关键词 安丝菌素P-3 珍贵橙色束丝放线菌 发酵 ansamitocin P-3 Actinosynnema pretiosurn fermentation
  • 相关文献

参考文献5

  • 1Higashide E,Asai M,Ootsu K. Ansamitocin,a group of novel maytansinoid antibiotics with antitumour properties from Nocardia[J].Nature,1977,(5639):721-722. 被引量:1
  • 2Cassady JM,Chan KK,Floss HG. Recent developments in the maytansinoid antitumor agents[J].Chemical and Pharmaceutical Bulletin(Tokyo),2004,(01):1-26.doi:10.1248/cpb.52.1. 被引量:1
  • 3Liu C,Tadayoni BM,Bourret LA. Eradication of large colon tumor xenografts by targeted delivery of maytansinoids[J].Proceedings of the National Academy of Sciences(USA),1996,(16):8618-8623.doi:10.1073/pnas.93.16.8618. 被引量:1
  • 4Hasegawa T,Izawa M,Nagaokakyo T. Antibiotic C-15003 PHM and production thereof[P].US,4450234,1984. 被引量:1
  • 5Lin J,Bai L,Deng Z. Enhanced production of ansamitocin P-3 by addition of isobutanol in fermentation of Actinosynnema pretiosum[J].Bioresource Technology,2011,(02):1863-1868. 被引量:1

同被引文献52

  • 1孙岚,张英鸽,杨留中.纳米活性炭在小鼠体内的分布、存留及淋巴靶向性[J].军事医学科学院院刊,2005,29(4):349-351. 被引量:16
  • 2张波,陈佳平,胡建昆.纳米炭混悬注射液检测胃癌前哨淋巴结的临床研究[J].华西医学,2006,21(3):514-515. 被引量:25
  • 3LAPUSAN S, VIDRIALES MB, THOMAS X, et al. Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate,in adult pa- tients with relapsed/refractory acute myeloid leukemia [J]. Invest New Drug, 2012, 30(3): 1121-1131. 被引量:1
  • 4VENGHATERI JB, GUPTA TK, VERMA PJ, et al. Ansamitocin P-3 Depolymerizes Microtubules and Induces Apoptosis by Binding to Tubulin at the Vinblastine Site[J]. Plos one, 2013,8(10): e75182. 被引量:1
  • 5GERBER HP, KOEHN FE, ABRAHAM RT. The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics [J]. Nat Prod Rep, 2013, 30(5): 625-639. 被引量:1
  • 6SIEVERS EL, SENTER PD. Antibody-drug conjugates in cancer therapy [J]. Annu Rev Med, 2013, 64:15-29. 被引量:1
  • 7TAFT F, BRUNJES M, KNOBLOCH T. Timing of the Δ 10,12-Δ 11,13 double bond bigration during ansamitocin biosynthesis in actinosyrmema pretiosum[J]. J Am Chem Soc, 2009, 131(11): 3812-3813. 被引量:1
  • 8WU Yingying, KANG Qianjin, SHANG Guangdong, et al. N-methylation of the amide bond by methyltransferase asm10 in ansamitocin biosynthe- sis[J]. Chembioehem, 2011, 12(11): 1759-1766. 被引量:1
  • 9YU TW, BAI LQ, CLADE D, et al. The biosynthetic gene cluster of the maytansinoid antitumor agent ansamitocin from Actinosynnema pretio- sum[J]. P Natl Aead Sci USA, 2002, 99(12): 7968-7973. 被引量:1
  • 10LIN Jinxia, BAI Linquan, DENG Zixin. Enhanced production of ansamitocin P-3 by addition of isobutanol in fermentation of Actinosyrmema pretiosum [J]. Bioresource Technol, 2011, 102 (2): 1863-1868. 被引量:1

引证文献9

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部